Clinical Trial Update: New Approaches in MRI at 3T Dedicated to Targeting Subthalamic Nucleus on Parkinsonian Patients [NA]

View source ↗

Summary

This clinical trial update describes new MRI approaches at 3T aimed at targeting the subthalamic nucleus in patients with Parkinson disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Parkinson Disease | NA | Status: ACTIVE_NOT_RECRUITING